Blog
Is Amphenol (APH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock
3 Reasons Why Banco Bilbao (BBVA) Is a Great Growth Stock
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great
Here is Why Growth Investors Should Buy Rockwell Automation (ROK) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock
6 Reasons Why You Should Add Ryanair Stock to Your Portfolio
Ryanair Holdings plc (RYAAY) is benefiting from the improvement in traffic from the pandemic-led slump. Measures to expand its fleet and bring down debt levels are encouraging, too.
Against this
SNOW Expands Portfolio on Acquisitions: What's Ahead for the Stock?
Snowflake SNOW is benefiting from its strategic acquisitions, which are significantly enhancing its portfolio and positioning the company as a leader in the data and AI space.The company’s
Humana Partners With Atlas to Enhance Cancer Care for Seniors
Humana Inc. HUM recently unveiled a tie-up with Atlas Oncology Partners in a bid to provide enhanced cancer care, particularly for Medicare beneficiaries. Starting Jan. 1, 2026, eligible Humana
Why Gold Mining Stocks May Still Have Room to Run
After climbing nearly 70% in 2025 and starting this year on strong footing, it may seem unreasonable to expect gold and gold mining stocks to deliver another year of outsized performance. Yet the
Will Accelerant Holdings (ARX) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Accelerant
Will Credicorp (BAP) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Credicorp
Why AerCap (AER) is Poised to Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider AerCap (AER)
Will Amentum (AMTM) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Amentum Holdings (AMTM), which belongs
Will Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Alkermes (ALKS), which belongs to the
Can Jack Henry (JKHY) Keep the Earnings Surprise Streak Alive?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Jack Henry (JKHY), which belongs to the
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Hinge Health Inc. (HNGE), which belongs
Will GXO Logistics (GXO) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider GXO Logistics
Why Trane Technologies (TT) Could Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Trane
Why First American Financial (FAF) is Poised to Beat Earnings Estimates Again
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering First American Financial (FAF), which belongs
Will Exelon (EXC) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Exelon (EXC), which belongs to the Zacks
Will Exelixis (EXEL) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Exelixis (EXEL), which belongs to the Zacks
Why East West Bancorp (EWBC) Could Beat Earnings Estimates Again
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering East West Bancorp (EWBC), which belongs to the
Will BorgWarner (BWA) Beat Estimates Again in Its Next Earnings Report?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider BorgWarner
Will Curtiss-Wright (CW) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Curtiss-Wright (CW), which belongs to the Zacks
Retail ETF (RTH) Touches New 52-Week High
For investors seeking momentum, VanEck Retail ETF RTH is probably on the radar now. The fund just hit a 52-week high and is up 28.2% from its 52-week low price of $206.24 per share.
But are there
China ETFs in Focus as Beijing's Trade Surplus Touches Record $1.2T
The world’s second-largest economy, in terms of GDP, has achieved a historic milestone by reporting an annual trade surplus worth a record $1.19 trillion for 2025, according to customs data released
Will Positive Data on Camzyos Strengthen BMY's Cardiovascular Portfolio?
Bristol Myers’ BMY cardiovascular portfolio currently comprises blockbuster drugs Eliquis and Camzyos.
The company recently reported positive top-line results from the late-stage SCOUT-HCM trial


